Related Experiment Video

Updated: Dec 24, 2025

Catheter-based Endovascular Angioplasty for Fibrosing Mediastinitis-associated Pulmonary Vein Stenosis
06:59

Catheter-based Endovascular Angioplasty for Fibrosing Mediastinitis-associated Pulmonary Vein Stenosis

Published on: August 26, 2025

459

Native valve fungal endocarditis caused by Aspergillus fumigatus: management dilemma

Mohammed A Aldosari1, Mohammed H Alghamdi1, Abdulrahman A Alhamdan1

  • 1King Abdulaziz Cardiac Center, King Abdulaziz Medical City, National Guard Health Affairs, Riyadh, Saudi Arabia.

Oxford Medical Case Reports
|April 8, 2020
PubMed

Insights

Fungal endocarditis (FE) is a serious condition with high mortality. This case highlights successful treatment of rare Aspergillus endocarditis in a native valve with combined medical and surgical therapy.

Area of Science:

  • Infectious Diseases
  • Cardiology
  • Mycology

Background:

  • Fungal endocarditis (FE) presents a significant mortality risk, often exceeding 50%, especially in patients with underlying health issues.
  • Candida albicans and Aspergillus fumigatus are the primary causative agents of FE.
  • While prior valvular surgery is a major risk factor for Aspergillus endocarditis, native valve involvement is exceptionally rare.

Observation:

  • This report details an uncommon case of native valve fungal endocarditis caused by Aspergillus fumigatus.
  • The patient presented with concurrent complications from Wegener's disease and prostate cancer.
  • The infection involved the native heart valve, a rare occurrence for Aspergillus endocarditis.

Findings:

  • Successful management was achieved through a combined approach of surgical intervention and antifungal medical therapy.
  • The patient survived the rare Aspergillus endocarditis with these integrated treatment strategies.
  • Diagnosis and treatment of Aspergillus endocarditis pose significant challenges.

Implications:

  • This case underscores the importance of prompt diagnosis and aggressive treatment for rare fungal endocarditis.
  • Combined surgical and medical management is crucial for improving survival rates in Aspergillus endocarditis.
  • Further research into optimal therapeutic strategies for rare fungal endocarditis is warranted.

More Related Videos

Histological Quantification to Determine Lung Fungal Burden in Experimental Aspergillosis09:52

Histological Quantification to Determine Lung Fungal Burden in Experimental Aspergillosis

Published on: March 9, 2018

10.9K
Live Imaging of Antifungal Activity by Human Primary Neutrophils and Monocytes in Response to A. fumigatus12:29

Live Imaging of Antifungal Activity by Human Primary Neutrophils and Monocytes in Response to A. fumigatus

Published on: April 19, 2017

10.6K

Related Concept Videos

Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
164
Endocarditis IV: Nursing Management01:29

Endocarditis IV: Nursing Management

Infective endocarditis (IE) is a chronic infection of the heart's endocardium, primarily affecting the heart valves. A detailed nursing assessment for a patient with IE involves collecting subjective and objective data to ensure an accurate diagnosis and timely intervention.Subjective DataThe nurse gathers information about the patient's symptoms and complaints during the subjective assessment. Patients with infective endocarditis often report non-specific symptoms that can mimic other...
245
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
182
Endocarditis I: Introduction01:25

Endocarditis I: Introduction

Introduction:Endocarditis is the infection of the endocardium, the inner lining of the heart and its valves. When the heart muscle is involved, the condition is termed myocarditis, while an infection of the outer lining is called pericarditis. Infective endocarditis (IE) primarily affects the endocardium, where pathogens adhere to the valves or lining, forming vegetation that can lead to severe complications. Infective endocarditis occurs when microorganisms, usually bacteria from other body...
313
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
121
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
199